HT
NVAX icon

HAP Trading’s Novavax NVAX Stock Holding History

HAP Trading’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-64,638
Closed -$3.35M – 2239
2022
Q1 		$4.76M Buy
64,638
+42,367
+190% +$3.78M 0.2% 88
2021
Q4 		$3.19M Buy
22,271
+9,367
+73% +$1.61M 0.09% 205
2021
Q3 		$2.67M Buy
+12,904
New +$2.84M 0.09% 220
2020
Q4 		– Sell
-38,755
Closed -$4.12M – 2385
2020
Q3 		$4.2M Buy
38,755
+5,064
+15% +$617K 0.21% 88
2020
Q2 		$2.81M Buy
+33,691
New +$1.29M 0.15% 105

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HAP Trading's NVAX Position: Q2 2022 in Review

HAP Trading sold out of Novavax (NVAX) in Q2 2022, closing a stake of 64,638 shares — an estimated $3.35M sold.

HAP Trading first reported a position in NVAX in Q2 2020 and held it in 5 quarters. The position peaked at $4.76M in Q1 2022. 326 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • HAP Trading reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • HAP Trading sold 64,638 Novavax shares in Q2 2022, an estimated $3.35M.
  • HAP Trading first reported a position in Novavax in Q2 2020 and held it in 5 quarters.
  • HAP Trading's Novavax position peaked at $4.76M in Q1 2022.
  • 326 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on HAP Trading's 13F filing for Q2 2022, filed 12 Aug 2022.